RU2300529C2 - Кристаллическая натриевая соль парекоксиба - Google Patents

Кристаллическая натриевая соль парекоксиба Download PDF

Info

Publication number
RU2300529C2
RU2300529C2 RU2004127585/04A RU2004127585A RU2300529C2 RU 2300529 C2 RU2300529 C2 RU 2300529C2 RU 2004127585/04 A RU2004127585/04 A RU 2004127585/04A RU 2004127585 A RU2004127585 A RU 2004127585A RU 2300529 C2 RU2300529 C2 RU 2300529C2
Authority
RU
Russia
Prior art keywords
sodium salt
parecoxib sodium
parecoxib
salt according
substantially corresponding
Prior art date
Application number
RU2004127585/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2004127585A (ru
Inventor
Ахмад Й. ШЕЙХ (US)
Ахмад Й. ШЕЙХ
Томас Р. БОРЧАРДТ (US)
Томас Р. БОРЧАРДТ
Леонард Дж. ФЕРРО (US)
Леонард Дж. Ферро
Жеральд Д. ДАНЦЕР (US)
Жеральд Д. ДАНЦЕР
Original Assignee
Фармация Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармация Корпорейшн filed Critical Фармация Корпорейшн
Publication of RU2004127585A publication Critical patent/RU2004127585A/ru
Application granted granted Critical
Publication of RU2300529C2 publication Critical patent/RU2300529C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
RU2004127585/04A 2002-03-15 2003-03-12 Кристаллическая натриевая соль парекоксиба RU2300529C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36456702P 2002-03-15 2002-03-15
US60/364,567 2002-03-15
US41798702P 2002-10-11 2002-10-11
US60/417,987 2002-10-11

Publications (2)

Publication Number Publication Date
RU2004127585A RU2004127585A (ru) 2005-04-10
RU2300529C2 true RU2300529C2 (ru) 2007-06-10

Family

ID=28045416

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004127585/04A RU2300529C2 (ru) 2002-03-15 2003-03-12 Кристаллическая натриевая соль парекоксиба

Country Status (18)

Country Link
US (1) US20030232871A1 (enExample)
EP (1) EP1485362A1 (enExample)
JP (1) JP2005529084A (enExample)
KR (1) KR100763045B1 (enExample)
CN (1) CN1642926A (enExample)
AR (1) AR038985A1 (enExample)
AU (1) AU2003220180A1 (enExample)
BR (1) BR0308431A (enExample)
CA (1) CA2478500A1 (enExample)
CO (1) CO5631437A2 (enExample)
IL (1) IL163780A0 (enExample)
MX (1) MXPA04008932A (enExample)
MY (1) MY148518A (enExample)
NZ (1) NZ535951A (enExample)
PL (1) PL372880A1 (enExample)
RU (1) RU2300529C2 (enExample)
TW (1) TW200400949A (enExample)
WO (1) WO2003078408A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050143431A1 (en) * 2003-04-04 2005-06-30 Hetero Drugs Limited Novel crystalline forms of parecoxib sodium
JP2007507538A (ja) 2003-10-02 2007-03-29 エラン ファーマシューティカルズ，インコーポレイテッド 疼痛軽減方法
JP2007517013A (ja) * 2003-12-24 2007-06-28 ファルマシア コーポレーション 炎症、疼痛および／または発熱の治療を目的としたｃｏｘ−２阻害薬バルデコキシブのプロドラッグとしてのパレコキシブ金属塩
ITMI20040019A1 (it) * 2004-01-12 2004-04-12 Univ Bari Derivati isossazolici e loro impiego come inibitori della ciclossigenasi
US7796785B2 (en) * 2005-03-03 2010-09-14 Fujifilm Corporation Image extracting apparatus, image extracting method, and image extracting program
US20080108664A1 (en) * 2005-12-23 2008-05-08 Liu Belle B Solid-state form of AMG 706 and pharmaceutical compositions thereof
US7989450B2 (en) 2008-01-11 2011-08-02 Universita' Degli Studi Di Bari Functionalized diarylisoxazoles inhibitors of ciclooxygenase
GB0919757D0 (en) * 2009-11-12 2009-12-30 Johnson Matthey Plc Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
US8299295B2 (en) 2009-10-15 2012-10-30 Johnson Matthey Public Limited Company Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
CN105726496B (zh) * 2014-12-12 2019-05-28 湖南科伦药物研究有限公司 一种帕瑞昔布钠冻干粉剂、其制备方法及其粉剂产品
CN105125506A (zh) * 2015-08-18 2015-12-09 上海秀新臣邦医药科技有限公司 一种注射用帕瑞昔布钠及其制备方法
CN106580893A (zh) * 2016-12-26 2017-04-26 上药东英（江苏）药业有限公司 一种帕瑞昔布钠冻干粉针制剂
CN106692079A (zh) * 2016-12-26 2017-05-24 上药东英（江苏）药业有限公司 一种帕瑞昔布钠长效冻干粉针制剂
CN117003769B (zh) * 2023-07-11 2024-11-22 中国科学院宁波材料技术与工程研究所 氯诺昔康复合物、氯诺昔康-小檗碱共晶及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932598A (en) * 1996-04-12 1999-08-03 G. D. Searle & Co. Prodrugs of benzenesulfonamide-containing COX-2 inhibitors
RU99110192A (ru) * 1996-10-15 2001-03-27 Джи. Ди. Сирл Энд Ко Способ применения ингибиторов циклооксигеназы-2 для лечения и профилактики неоплазии

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100558356C (zh) * 1996-10-15 2009-11-11 G.D.瑟尔公司 应用环加氧酶-2抑制剂治疗和预防肿瘤形成的方法
PE20021017A1 (es) * 2001-04-03 2002-11-24 Pharmacia Corp Composicion parenteral reconstituible
IL161086A0 (en) * 2001-10-02 2004-08-31 Pharmacia Corp Method for preparing benzenesulfonyl compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932598A (en) * 1996-04-12 1999-08-03 G. D. Searle & Co. Prodrugs of benzenesulfonamide-containing COX-2 inhibitors
RU99110192A (ru) * 1996-10-15 2001-03-27 Джи. Ди. Сирл Энд Ко Способ применения ингибиторов циклооксигеназы-2 для лечения и профилактики неоплазии

Also Published As

Publication number Publication date
PL372880A1 (en) 2005-08-08
JP2005529084A (ja) 2005-09-29
EP1485362A1 (en) 2004-12-15
KR100763045B1 (ko) 2007-10-04
CA2478500A1 (en) 2003-09-25
KR20040095288A (ko) 2004-11-12
CO5631437A2 (es) 2006-04-28
RU2004127585A (ru) 2005-04-10
MXPA04008932A (es) 2004-11-26
US20030232871A1 (en) 2003-12-18
AU2003220180A1 (en) 2003-09-29
AR038985A1 (es) 2005-02-02
NZ535951A (en) 2006-02-24
CN1642926A (zh) 2005-07-20
IL163780A0 (en) 2005-12-18
WO2003078408A1 (en) 2003-09-25
MY148518A (en) 2013-04-30
BR0308431A (pt) 2005-01-18
TW200400949A (en) 2004-01-16

Similar Documents

Publication Publication Date Title
RU2300529C2 (ru) Кристаллическая натриевая соль парекоксиба
JP6386478B2 (ja) メチル｛４，６−ジアミノ−２−［１−（２−フルオロベンジル）−１ｈ−ピラゾロ［３，４−ｂ］ピリジノ−３−イル］ピリミジノ−５−イル｝メチルカルバメートの形態
TW202335670A (zh) ｛［５—（３—氯苯基）—３—羥基吡啶—２—羰基］胺基｝乙酸之固體型式，其組合物及用途
JP2006137778A (ja) ゾルピデムヘミタートレイト
JP2003513961A (ja) シクロオキシゲナーゼ−２の阻害剤である５−アリール−１ｈ−１，２，４−トリアゾール化合物とそれを含む医薬品組成物
TWI837089B (zh) 製備雜環衍生化合物之方法、包括該化合物之組成物及該化合物之水合物
EP1446118B1 (en) Oral dosage form of parecoxib
EP3447054A1 (en) Compound and preparation method therefor, composition and application thereof
TW200808317A (en) Compounds for treating pulmonary hypertension
WO2016145622A1 (zh) 苯并咪唑衍生物及其制备方法和医药用途
TW200900392A (en) Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same
US20040092566A1 (en) Celecoxib prodrug
ZA200406788B (en) Crystalline parecoxib sodium
EA006245B1 (ru) Гидрохлорид 4-[4-(2-пирролилкарбонил)-1-пиперазинил]-3-трифторметилбензоилгуанидина
US20250197393A1 (en) Integrin inhibitor and uses thereof
HK1075049A (en) Crystalline parecoxib sodium
HK1106529A (en) Crystalline parecoxib sodium
HK1106528A (en) Crystalline parecoxib sodium
CN118666859A (zh) 具有mgat2抑制活性的稠合环衍生物的制造方法
TW200526659A (en) New compounds
EP1604663A1 (en) Zolpidem Hemitartrate Form H Solvate
HK1081546A (zh) 塞來考昔的前藥

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20060207

FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20060626

MM4A The patent is invalid due to non-payment of fees

Effective date: 20090313